Slingshot members are tracking this event:

FibroGen (FGEN) aiming to complete submission for roxadustat in India in 2017 Q3

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
FGEN Community voting in process

Additional Information

Additional Relevant Details Update on oct 28 2017: Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD)
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Roxadustat, India